Efficacy and Safety Study of Aplindore in Patients With Early Parkinson Disease
This study has been terminated.
(Neurogen acquired by Ligand Pharmaceuticals - no further support for study. No safety concerns identified.)
Sponsor:
Neurogen Corporation
Information provided by:
Neurogen Corporation
ClinicalTrials.gov Identifier:
NCT00809302
First received: December 15, 2008
Last updated: August 27, 2009
Last verified: August 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Estimated Study Completion Date: | October 2009 |
| Estimated Primary Completion Date: | August 2009 (Final data collection date for primary outcome measure) |